Rebecca Mann Flueckiger

Rebecca Mann Flueckiger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rebecca Mann Flueckiger has a total of 282 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Camel leasing as a resilience-building practice: Insights from Somali pastoralist households and dairy farms

    by Emily Decker, Rebecca M. Flueckiger, Micah Frumkin, Rebecca H. Jeudin, Christelle Celestin, Abdul Kareem Osman Essa, Ezgi E. Yilmaz


  • Open Access

    Evaluating Precision of a Trachomatous Trichiasis (TT) Super Survey with Modulating Sample Sizes in Tanzania

    by Rebecca M. Flueckiger, Rachel Stelmach, Clara R. Burgert-Brucker, Paul Courtright, George Kabona, Aryc W. Mosher, Upendo J. Mwingira, Jennifer C. Harding, Alistidia Simon, Jeremiah Ngondi

    As trachoma programs move towards eliminating trachoma as a public health problem, the number of surveys necessary to evaluate the status of trachomatous trichiasis (TT) increases. Currently, the World Health Organization endorses a district-level population-based prevalence survey for trachoma that involves a two-stage cluster design. We explored the validity of implementing this survey design in larger geographic areas to gain cost efficiencies. We evaluated the change in precision due to combining geographically contiguous and homogenous districts into single evaluation units (EUs) and modulating the sample size by running simulations on existing datasets. Preliminary findings from two opportunities in Tanzania show variability in the appropriateness in conducting this survey across larger geographies. These preliminary findings stress the importance of determining what is meant by homogeneity in terms of TT before combining multiple districts into a single EU.


  • Open Access

    Trachomatous Trichiasis (TT) management in Tanzania: a mixed method study investigating barriers and facilitators to obtaining treatment

    by Rebecca M. Flueckiger, George Kabona, Upendo Mwingira, Alistidia Simon, Jeremiah Ngondi

    Background: Prolonged ocular Chlamydial infection, known as trachoma, can lead to trachomatous trichiasis (TT). TT is the stage of trachoma where the eyelid turns inwards, resulting in lashes rubbing against the cornea. TT can damage the cornea, leading to vision impairment or blindness. Treatment for TT includes epilation or surgery. Trachoma is targeted for elimination as a public health problem. One criterion of trachoma elimination is less than 0.2% prevalence of TT unknown to the health system in adults >= 15 years. There are several districts in Tanzania that have not attained this target. Methodology: We selected six districts across three regions in Tanzania. Our mixed-methods approach included a retrospective review and analysis of program data and implementation of key informant interviews (KII) and focus group discussions (FGD). The desk review collated data on district-level indicators and generated estimates around number and proportion of cases not identified by case finders and cases lost along the continuum of care. KIIs and FGDs guides were structured to enlist responses around case finding techniques, linkage to services and TT surgery process. Conclusion: We found a substantial proportion (13%) of TT positive people were not being identified by case finders, and of those identified, majority (72%) were lost along the continuum of care. These factors likely contribute to high TT prevalence in districts where surgical interventions are ongoing. Engaging community leaders to share TT information and enlisting people who have received surgery to witness in communities may encourage consent of examination by case finders and increase surgical uptake. After witnessing positive effects of surgery, many interviewees who had previously declined surgery changed their mind. Increasing frequency of surgical camps would improve access to these populations. Additionally, giving more notice about surgical camps and extending duration is important to enable remote populations to obtain services. Author Summary: Treatment for trachomatous trichiasis (TT) includes epilation or surgery. There are several districts in Tanzania that have struggled to link people with TT to services. It is important for the program to understand why this is the case to inform program adaptations for improved linkage to services. We implemented a mixed methods approach to address this knowledge gap. We found a large portion of TT positive people are not being identified by case finders and of those identified, many are lost along the continuum of care. These factors are likely contributing to the unexpectedly high TT prevalence in districts where surgical interventions are ongoing. Barriers to identifying cases included remoteness, case finder credibility, knowledge of TT, and case finder motivation. Once cases are identified, the largest gap along the continuum of care is the link between being identified and screened. We found barriers to attending screenings and subsequently obtaining treatment to be fear of surgery, distance from surgical camps, agricultural season, time to plan, awareness and frequency of camps, and lack of assistance after surgery.


  • Open Access

    The global burden of trichiasis in 2016

    by Rebecca M. Flueckiger, Paul Courtright, Mariamo Abdala, Amza Abdou, Zaid Abdulnafea, Tawfik K. Al-Khatib, Khaled Amer, Olga Nelson Amiel, Sossinou Awoussi, Ana Bakhtiari, et al.

    Trichiasis is present when one or more eyelashes touches the eye. Uncorrected, it can cause blindness. Accurate estimates of numbers affected, and their geographical distribution, help guide resource allocation. We obtained district-level trichiasis prevalence estimates in adults for 44 endemic and previously-endemic countries. We used (1) the most recent data for a district, if more than one estimate was available; (2) age- and sex-standardized corrections of historic estimates, where raw data were available; (3) historic estimates adjusted using a mean adjustment factor for districts where raw data were unavailable; and (4) expert assessment of available data for districts for which no prevalence estimates were available. Internally age- and sex-standardized data represented 1,355 districts and contributed 662 thousand cases (95% confidence interval [CI] 324 thousand–1.1 million) to the global total. Age- and sex-standardized district-level prevalence estimates differed from raw estimates by a mean factor of 0.45 (range 0.03–2.28). Previously non- stratified estimates for 398 districts, adjusted by ×0.45, contributed a further 411 thousand cases (95% CI 283–557 thousand). Eight countries retained previous estimates, contributing 848 thousand cases (95% CI 225 thousand-1.7 million). New expert assessments in 14 countries contributed 862 thousand cases (95% CI 228 thousand–1.7 million). The global trichiasis burden in 2016 was 2.8 million cases (95% CI 1.1–5.2 million). The 2016 estimate is lower than previous estimates, probably due to more and better data; scale-up of trichiasis management services; and reductions in incidence due to lower active trachoma prevalence. As an individual with trichiasis blinks, the eyelashes abrade the cornea, which can lead to corneal opacity and blindness. Through high quality surgery, which involves altering the position of the eyelid margin, it is possible to reduce the number of people with trichiasis. Accurate estimates of the number of persons with trichiasis and their geographical distribution are needed in order to effectively align resources for surgery and other necessary services. We obtained district-level trichiasis prevalence estimates for 44 endemic and previously-endemic countries. We used the most recently available data and expert assessments to estimate the global burden of trichiasis. We estimated that in 2016 the global burden was 2.8 million cases (95% CI 1.1–5.2 million). The 2016 estimate is lower than previous estimates, probably due to more and better data; scale-up of trichiasis management services; and reductions in incidence due to lower active trachoma prevalence.


  • Using Short Message Service Alerts to Increase Antenatal Care and Malaria Prevention: Findings from Implementation Research Pilot in Guinea

    by Rebecca Mann Flueckiger, Diallo M. Thierno, Rajeev Colaço, Timothée Guilavogui, Lamine Bangoura, Richard Reithinger, Elizabeth Regan Fitch, Jean-Luc Taton, Aissata Fofana

    Intermittent preventive treatment with sulfadoxine–pyrimethamine (SP) is recommended to prevent malaria in pregnancy. Treatment coverage, particularly for three or more doses, is dependent on pregnant women attending antenatal care (ANC) services as scheduled. The StopPalu project pilot tested short message services (SMSs) to remind women of upcoming ANC visits in the Conakry and Kindia regions of Guinea. Health facilities were selected as pilot and comparison facilities. All women who attended an initial ANC visit at a selected facility during the pilot period and had access to a mobile telephone were enrolled. The pilot group was sent an SMS before each appointment. Percentage of attendance and SP distribution were calculated. A log-binomial regression model determined odds ratios. Pregnant women receiving SMS were 48 times more likely to attend all visits and were 12 times more likely to receive all SP doses during pregnancy.


  • Open Access

    The costs of monitoring trachoma elimination: Impact, surveillance, and trachomatous trichiasis (TT)-only surveys

    by Rachel D Stelmach, Rebecca M Flueckiger, John Shutt, Margaret Davide-Smith, Anthony W Solomon, Lisa Rotondo, Aryc W Mosher, Margaret Baker, Rebecca Willis, Jeremiah Ngondi

    Although trachoma causes more cases of preventable blindness than any other infectious disease, a combination of strategies is reducing its global prevalence. As a district moves toward eliminating trachoma as a public health problem, national programs conduct trachoma impact surveys (TIS) to assess whether to stop preventative interventions and trachoma surveillance surveys (TSS) to determine whether the prevalence of active trachoma has rebounded after interventions have halted. In some contexts, programs also conduct trachomatous trichiasis (TT)-only surveys. A few costing studies of trachoma prevalence surveys exist, but none examine TIS, TSS, or TT-only surveys. We assessed the incremental financial cost to the national program of TIS, TSS, and TT-only surveys, which are standardized cluster-sampled prevalence surveys. We conducted a retrospective review of expenditures and grant disbursements for TIS and TSS in 322 evaluation units in 11 countries between 2011 and 2018. We also assessed the costs of three pilot and five standard TT-only surveys in four countries between 2017 and 2018. The median cost of TIS and TSS was $8,298 per evaluation unit [interquartile range (IQR): $6,532–$10,111, 2017 USD]. Based on a linear regression with bootstrapped confidence intervals, after controlling for country, costs per survey did not change significantly over time but did decline by $83 per survey implemented in a single round (95% CI: -$108 –-$63). Of total costs, 80% went to survey fieldwork; of that, 58% went towards per diems and 38% towards travel. TT-only surveys cost a median of $9,707 (IQR: $8,537–$11,635); within a given country, they cost slightly more (106% [IQR: 94%–136%]) than TIS and TSS. The World Health Organization requires trachoma prevalence estimates for validating the elimination of trachoma as a public health problem. This study will help programs improve their planning as they assemble resources for that effort. The global health community is working to eliminate trachoma, a bacterial disease that causes blindness. The elimination strategy includes offering antibiotics to everyone living in communities with a high prevalence of active trachoma, also known as mass drug administration, and providing surgeries for people with advanced trachoma. The World Health Organization requires that countries conduct surveys to see whether a district has reached the prevalence benchmarks for stopping population-level prevention interventions against trachoma. After stopping these interventions, programs conduct more surveys to make sure that trachoma has remained at bay. Trachoma programs must include the costs of these surveys in their budgets. Although some estimates of the costs of baseline trachoma prevalence surveys already exist, none examine the costs of additional surveys required later in the program. In this paper, we analyze the costs of over 300 of these surveys. We find that they cost about $8,000-$10,000 per survey, varying widely by country. Variations are mostly driven by how much it costs to pay surveyors and transport them to survey sites. Costs did not appear to change over time. With the data that we present in this paper, national programs will be more prepared to plan for monitoring the elimination of trachoma.


  • Open Access

    Understanding the spatial distribution of trichiasis and its association with trachomatous inflammation—follicular

    by Rebecca Mann Flueckiger, Emanuele Giorgi, Jorge Cano, Mariamo Abdala, Olga Nelson Amiel, Gilbert Baayenda, Ana Bakhtiari, Wilfrid Batcho, Kamal Hashim Bennawi, Michael Dejene, et al.

    Whilst previous work has identified clustering of the active trachoma sign “trachomatous inflammation—follicular” (TF), there is limited understanding of the spatial structure of trachomatous trichiasis (TT), the rarer, end-stage, blinding form of disease. Here we use community-level TF prevalence, information on access to water and sanitation, and large-scale environmental and socio-economic indicators to model the spatial variation in community-level TT prevalence in Benin, Cote d’Ivoire, DRC, Guinea, Ethiopia, Malawi, Mozambique, Nigeria, Sudan and Uganda. We fit binomial mixed models, with community-level random effects, separately for each country. In countries where spatial correlation was detected through a semi-variogram diagnostic check we then fitted a geostatistical model to the TT prevalence data including TF prevalence as an explanatory variable. The estimated regression relationship between community-level TF and TT was significant in eight countries. We estimate that a 10% increase in community-level TF prevalence leads to an increase in the odds for TT ranging from 20 to 86% when accounting for additional covariates. We find evidence of an association between TF and TT in some parts of Africa. However, our results also suggest the presence of additional, country-specific, spatial risk factors which modulate the variation in TT risk.


  • Open Access

    Quality Assurance and Quality Control in the Global Trachoma Mapping Project

    by Anthony W. Solomon, Rebecca Willis, Alexandre L. Pavluck, Wondu Alemayehu, Ana Bakhtiari, Sarah Bovill, Brian K. Chu, Paul Courtright, Michael Dejene, Philip Downs, et al.

    In collaboration with the health ministries that we serve and other partners, we set out to complete the multiple-country Global Trachoma Mapping Project. To maximize the accuracy and reliability of its outputs, we needed in-built, practical mechanisms for quality assurance and quality control. This article describes how those mechanisms were created and deployed. Using expert opinion, computer simulation, working groups, field trials, progressively accumulated in-project experience, and external evaluations, we developed 1) criteria for where and where not to undertake population-based prevalence surveys for trachoma; 2) three iterations of a standardized training and certification system for field teams; 3) a customized Android phone–based data collection app; 4) comprehensive support systems; and 5) a secure end-to-end pipeline for data upload, storage, cleaning by objective data managers, analysis, health ministry review and approval, and online display. We are now supporting peer-reviewed publication. Our experience shows that it is possible to quality control and quality assure prevalence surveys in such a way as to maximize comparability of prevalence estimates between countries and permit high-speed, high-fidelity data processing and storage, while protecting the interests of health ministries.


  • A community led innovation benefiting women and children: Health facilities and credit cooperative work together to promote maternal health care in Sahare VDC, Nepal

    by Rebecca M. Flueckiger, Rajeev Colaco, Bibek Adhikari, Joshi Palas, Ghanshyam Kandel, Julia Kish Doto, Shova Lama, Robert Timmons, Damodar Adhikari

    Monetary incentives effectively promote antenatal care (ANC) attendance. However, in Nepal, late release of incentives is common, which leads to delays in payment to mothers, thereby negating the intended motivation. We evaluate a novel innovation where community organizers partnered with a Women’s Saving and Credit Cooperative to provide interest-free loans for timely distribution to mothers. Through focus group discussions and interviews we found that monetary incentives motivate women to seek ANC services and timely incentives provide critical commodities postpartum. This qualitative evaluation shows the importance of timeliness in delivery of incentives and demonstrates the success of a community partnership innovation.


  • Open Access

    The Epidemiology of Trachoma in Mozambique: Results of 96 Population-Based Prevalence Surveys

    by Mariamo Abdala, Carlos C. Singano, Rebecca Willis, Colin K. Macleod, Sharone Backers, Rebecca M. Flueckiger, Anselmo Vilanculos, Dantew Terefe, Moises Houane, Fitsum Bikele, et al.

    Purpose: Surveys are needed to guide trachoma control efforts in Mozambique, with WHO guidelines for intervention based on the prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9 years and the prevalence of trichiasis in adults aged 15 years and above. We conducted surveys to complete the map of trachoma prevalence in Mozambique. Methods: Between July 2012 and May 2015, we carried out cross-sectional surveys in 96 evaluation units (EUs) covering 137 districts. Results: A total of 269,217 individuals were enumerated and 249,318 people were examined using the WHO simplified trachoma grading system. Overall, 102,641 children aged 1–9 years, and 122,689 individuals aged 15 years and above were examined. The prevalence of TF in children aged 1–9 years was ≥10% in 12 EUs, composed of 20 districts, covering an estimated total population of 2,455,852. These districts require mass distribution of azithromycin for at least 3 years before re-survey. The TF prevalence in children was 5.0–9.9% in 17 EUs (28 districts, total population 3,753,039). 22 EUs (34 districts) had trichiasis prevalences ≥0.2% in adults 15 years and above, and will require public health action to provide surgical services addressing the backlog of trichiasis. Younger age, more children resident in the household, and living in a household that had an unimproved latrine or no latrine facility, were independently associated with an increased odds of TF in children aged 1–9 years. Conclusions: Trachoma represents a significant public health problem in many areas of Mozambique.